Guido Seitz

Title: Guido Seitz: Innovator in Tumor Marker Research

Introduction

Guido Seitz is a notable inventor based in Ammerbuch, Germany. He has made significant contributions to the field of medical research, particularly in the development of tumor markers.

Latest Patents

Guido Seitz holds a patent for a tumor marker related to rhabdomyosarcoma. The patent describes a nucleic acid molecule that encodes a splice variant of the human P2RX7 receptor. It includes nucleic acid molecules derived from this, a recombinant vector containing these nucleic acids, and a host that contains the recombinant vector. Additionally, it covers a polypeptide encoded by the nucleic acid molecules, a host cell expressing this polypeptide, and a binding molecule that interacts with the polypeptide. The patent also outlines a pharmaceutical composition that includes the binding molecule, methods for producing the isolated polypeptide, and various other methods and uses associated with this invention.

Career Highlights

Throughout his career, Guido Seitz has worked with esteemed institutions such as Eberhard Karls Universität Tübingen Medizinische Fakultät and Deutsches Krebsforschungszentrum Stiftung Des Öffentlichen Rechts. His work in these organizations has contributed to advancements in cancer research and treatment.

Collaborations

Guido Seitz has collaborated with notable colleagues, including Sorin Armeanu-Ebinger and Harald Surowy. These partnerships have fostered innovation and progress in their shared field of research.

Conclusion

Guido Seitz is a distinguished inventor whose work in tumor marker research has the potential to impact cancer diagnostics and treatment significantly. His contributions to the scientific community are noteworthy and continue to inspire future innovations.